8 participants
Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2015-12-01
- Start Date:
- 2009-02-28
- Completion:
- 2013-01-31
Conditions
- Metastatic Renal Cell Carcinoma
Interventions
- BIOLOGICAL
- DRUG